Perrigo (PRGO) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs
May 31, 2017 5:12 AM EDTGoldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.
Analyst Jami Rubin writes to clients in a late Tuesday note that RX prices have eroded 11-13 percent compared with company guidance of 9-11 percent for FY 2017.
"...we calculate... More
Perrigo (PRGO) Files Form 10-Q; Reports Q1 Results
May 30, 2017 5:17 PM EDTDelivered first quarter 2017 GAAP ("reported") net sales of $1.2 billion, led by consumer-facing businesses net sales of $958 millionRealized first quarter reported net income of $72 million and reported earnings per share ("EPS") of $0.50Achieved adjusted net income of $150 million and adjusted diluted EPS of $1.05First quarter cash flow from operations was $195 million; cash flow from operations of 272% as a percentage to net income and 130% as a percentage to adjusted net income CHCI profit improvement plan yielding positive results... More



